JP Fermand
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Bone health and treatments
Papers in
-
- Multiple Myeloma Research and Treatments 8
- Hematopoietic Stem Cell Transplantation 2
- Oncology 6
- Cancer Treatment and Pharmacology 5
- Co-authors
- J C Brouet (8 shared papers)Philippe Ravaud (3 shared papers)J M Cosset (2 shared papers)Yves Lévy (1 shared paper)M Benbunan (2 shared papers)J Gerota (2 shared papers)Sylvie Castaigné (4 shared papers)M Séligmann (2 shared papers)
- Journals
- Blood (6 papers)Haematologica (1 paper)European Respiratory Journal (1 paper)The American Journal of Medicine (1 paper)Journal of Bone and Mineral Research (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
JP Fermand
14 papers receiving 364 citations
Peers
Comparison fields: 5 of 46
- Hematology 314
- Oncology 150
- Genetics 55
- Molecular Biology 127
- Pathology and Forensic Medicine 26
Countries citing papers authored by JP Fermand
This map shows the geographic impact of JP Fermand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JP Fermand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JP Fermand more than expected).
Fields of papers citing papers by JP Fermand
This network shows the impact of papers produced by JP Fermand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JP Fermand. The network helps show where JP Fermand may publish in the future.
Co-authors
The 25 scholars most cited alongside JP Fermand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 133 | |
| 2 | 1993 | 105 | |
| 3 | 2011 | 37 | |
| 4 | 1992 | 33 | |
| 5 | 1997 | 16 | |
| 6 | 2001 | 15 | |
| 7 | 2003 | 13 | |
| 8 | 1992 | 8 | |
| 9 | 1983 | 7 | |
| 10 | 1993 | 6 | |
| 11 | 1989 | 4 | |
| 12 | 1985 | 3 | |
| 13 | 2009 | 2 | |
| 14 | Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation. | 1992 | 2 |
About JP Fermand
JP Fermand is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 14 papers that have together received 384 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Cancer Treatment and Pharmacology (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Hematology (314 citations), Oncology (150 citations), Genetics (55 citations), Molecular Biology (127 citations) and Pathology and Forensic Medicine (26 citations). JP Fermand has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include J C Brouet, Philippe Ravaud, J M Cosset, Yves Lévy, M Benbunan, J Gerota, Sylvie Castaigné, M Séligmann, V. Leblond and Sylvie Chevret. Their work appears in journals such as Blood, Haematologica, European Respiratory Journal, The American Journal of Medicine and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.